Clinical Trial Update: Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating neoadjuvant cadonilimab plus chemotherapy after short-course radiotherapy in locally advanced rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Cadonilimab

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Locally Advanced Rectal Carcinoma | Phase 2 | Status: COMPLETED